Accumulating data obtained from various animal species indicate that v
asopressin (AVP) participates in the regulation of adrenocortical func
tion. AVP doubled aldosterone and cortisol secretion but did not affec
t corticosterone secretion. Pharmacological studies indicate that the
AVP receptors in the cortex belong to the V1 a subtype. Activation of
V1 a receptors induces breakdown of membrane phosphoinositides, with s
ubsequent accumulation of inositol phosphates and diacylglycerol. Thes
e effects occur after receptor binding, G-protein activation and coupl
ing to a specific phospholipase C. Inositol trisphosphate, transiently
produced, induces a rapid release of Ca2+ from intracellular stores.
Diacylglycerol activates protein kinase C, which, together with calciu
m, is responsible for steroid secretion. The early events of AVP actio
n are mediated by two types of G-proteins. One is coupled to phospholi
pase C, and insensitive to pertussis toxin (probably G(q)/(11)) and a
second one, which is inactivated by pertussis toxin (G(i) protein), is
involved in the stimulation of calcium influx. This Ca2+ influx pathw
ay is very important, as no steroidogenic effect of AVP could be obser
ved when experiments were performed in a calcium-free medium or in per
tussis toxin-treated cells. Besides the pituitary, the adrenal is also
a source for AVP production. Indeed, AVP is synthesized and secreted
by chromaffin cells either present in the medulla or scattered through
out the cortex with a more prominent concentration in zona glomerulosa
. AVP receptors are also present on chromaffin cells. However, in cont
rast to AVP receptors in the cortex, these mainly belong to the V1b su
btype, although V1 a receptors are also detected. The results summariz
ed in this review conclusively indicate that AVP is one of the regulat
ors of both cortex and medulla, an influence which may be mediated in
part via pituitary AVP and in part via local production of AVP.